Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Tuesday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Tuesday. The firm has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.04. The stock has a market capitalization of $2,951.00, a P/E ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $2.91.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.